Skip Navigation


NDT Advance Access originally published online on February 23, 2009
Nephrology Dialysis Transplantation 2009 24(6):1962-1969; doi:10.1093/ndt/gfp067
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/6/1962    most recent
gfp067v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wang, A. Y.-M.
Right arrow Articles by Sanderson, J. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, A. Y.-M.
Right arrow Articles by Sanderson, J. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients

Angela Yee-Moon Wang1,*, Christopher Wai-Kei Lam2, Mei Wang1,*, Iris Hiu-Shuen Chan2, Siu-Fai Lui1, Yan Zhang1 and John E. Sanderson1,{dagger}

1 Department of Medicine & Therapeutics 2 Department of Chemical Pathology, the Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong

Correspondence and offprint requests to: Angela Yee-Moon Wang; E-mail: aymwang{at}hku.hk



  Abstract

Background. N-terminal-pro-brain natriuretic peptide, cardiac troponin T (cTnT) and high sensitivity C-reactive protein (hs-CRP) have been shown to predict mortality and cardiovascular outcomes in end-stage renal disease patients. However, it is not known which biomarkers have the strongest diagnostic potential for left ventricular (LV) abnormalities in chronic peritoneal dialysis (PD) patients, nor whether residual renal function may confound the diagnostic potential of these biomarkers.

Methods. Two hundred and thirty chronic PD patients underwent two-dimensional echocardiography to determine LV hypertrophy and ejection fraction and had simultaneous measurement of serum NT-pro-BNP, cTnT and hs-CRP.

Results. A significant gain in predictive power was observed when NT-pro-BNP or cTnT but not hs-CRP was included in the multivariable logistic regression models for severe LV hypertrophy (defined as LV mass index ≥ upper tertile, 247.8 g/m2) and systolic dysfunction (defined as ejection fraction ≤45%). Using ROC curve analysis, NT-pro-BNP had the highest diagnostic value for severe LV hypertrophy and systolic dysfunction compared to cTnT and hs-CRP, irrespective of residual renal function. An analysis based on the best cut-off threshold showed that NT-pro-BNP and cTnT had a negative predictive value of 87.1% and 92.6% for severe LV hypertrophy and 95.4% and 93.2% for systolic dysfunction, respectively. Furthermore, the best cut-off threshold of NT-pro-BNP and cTnT for excluding severe LV hypertrophy and systolic dysfunction was nearly 3-fold higher in anuric patients than in patients with residual renal function.

Conclusions. Serum NT-pro-BNP appeared most useful in excluding systolic dysfunction in chronic PD patients followed by cTnT. hs-CRP was not useful in this regard. Residual renal function confounded the interpretation of these biomarkers and reduced their predictive power. A nearly 30% higher cut-off threshold of NT-pro-BNP and cTnT had to be applied in anuric PD patients.

Keywords: cardiac troponin T; left ventricular hypertrophy; natriuretic peptide; peritoneal dialysis; systolic dysfunction

* Current address: Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong.

{dagger} Department of Cardiovascular Medicine, The Medical School, University of Birmingham, Birmingham, UK.

Received for publication: 13.10.08
Accepted in revised form: 2. 2.09


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.